Income tax expense/(credit) (Tables) - Alps Life Science Inc [Member]
|
12 Months Ended |
Mar. 31, 2025 |
IfrsStatementLineItems [Line Items] |
|
Schedule of income tax (credit)/ expense |
Schedule
of income tax (credit)/ expense
| |
2025 | | |
2024 | |
| |
USD | | |
USD | |
| |
| | |
| |
Estimated tax payable: | |
| | | |
| | |
Current
financial year | |
| 74,319 | | |
| - | |
| |
| | | |
| | |
Deferred tax (Note 20): | |
| | | |
| | |
Current
financial year | |
| 21,243 | | |
| (7,414 | ) |
| |
| | | |
| | |
Income
tax credit/(expense) | |
| 95,562 | | |
| (7,414 | ) |
|
Schedule of reconciliation of income tax credit |
A
reconciliation of income tax credit applicable to loss before tax at the applicable statutory income tax rate to income tax expense at
the effective income tax rate of the Group is as follows:
Schedule
of reconciliation of income tax credit
| |
2025 | | |
2024 | |
| |
USD | | |
USD | |
| |
| | |
| |
Loss
before tax | |
| (2,529,176 | ) | |
| (2,398,575 | ) |
| |
| | | |
| | |
Taxation at statutory rate of 24% (2024:
24%) | |
| (607,002 | ) | |
| (575,658 | ) |
Tax effects of: | |
| | | |
| | |
Non-taxable income | |
| - | | |
| (1,089 | ) |
Expenses not deductible | |
| 275,376 | | |
| 500,620 | |
Utilisation of deferred tax assets previously
not recognised | |
| (14,255 | ) | |
| (128,509 | ) |
Deferred tax assets
not recognised | |
| 441,443 | | |
| 197,222 | |
| |
| | | |
| | |
Income
tax credit/(expense) | |
| 95,562 | | |
| (7,414 | ) |
|
Schedule of estimated amount of temporary differences |
At
the end of the reporting period, the estimated amount of deductible temporary differences, unabsorbed capital allowances and unutilised
tax losses of the Group, for which the deferred tax assets have not been recognised in the financial statements due to uncertainty of
their realisation, is as follows:
Schedule
of estimated amount of temporary differences
| |
2025 | | |
2024 | |
| |
USD | | |
USD | |
| |
| | |
| |
Temporary differences arising from: | |
| | | |
| | |
Property,
plant and equipment | |
| (915,782 | ) | |
| (779,847 | ) |
Right-of-use assets
and lease liabilities | |
| 11,878 | | |
| 33,756 | |
Unabsorbed capital allowances | |
| 844,381 | | |
| 1,066,649 | |
Unutilised tax losses | |
| 5,388,164 | | |
| 3,228,133 | |
Temporary
differences | |
| 5,388,164 | | |
| 3,228,133 | |
| |
| | | |
| | |
Temporary
differences | |
| 5,328,641 | | |
| 3,548,691 | |
|
Schedule of unutilised tax losses |
Expiry
date of the unutilised tax losses is summarised below:
Schedule
of unutilised tax losses
| |
2025 | | |
2024 | |
| |
USD | | |
USD | |
| |
| | |
| |
Year of assessment: | |
| | | |
| | |
2028 | |
| - | | |
| 231,643 | |
2029 | |
| 21,403 | | |
| 229,885 | |
2030 | |
| 533,347 | | |
| 594,916 | |
2031 | |
| 1,025,589 | | |
| 1,070,286 | |
2032 | |
| 567,525 | | |
| 592,259 | |
2033 | |
| 487,881 | | |
| 509,144 | |
2034 | |
| 2,752,419 | | |
| - | |
| |
| | | |
| | |
Unutilised
tax losses | |
| 5,388,164 | | |
| 3,228,133 | |
|